Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study

This study supported intravenous vortioxetine as a means of rapidly reaching therapeutic vortioxetine blood levels.
Source: International Clinical Psychopharmacology - Category: Psychiatry Tags: Original Articles Source Type: research